LIU, Chunjian,YANG, Michael G.,XIAO, Zili,CHEN, Ling,MOSLIN, Ryan M.,TOKARSKI, John S.,WEINSTEIN, David S.,WROBLESKI, Stephen
申请号:
SG11202004592T
公开号:
SG11202004592TA
申请日:
2018.11.19
申请国别(地区):
SG
年份:
2020
代理人:
摘要:
or a stereoisomer or pharmaceutically-acceptable salt thereof, where R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.